Cargando…
miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F
Hepatocellular carcinoma (HCC) is a kind of malignant tumor derived from hepatocytes and hepatobiliary cells, and its occurrence is prevalent worldwide. Although medical technology is developing rapidly, the therapeutic efficacy of HCC is still poor. Emerging evidence manifests that microRNAs (miRNA...
Autores principales: | Ye, Xiangyang, Qiu, Rongxian, He, Xiongzhi, Hu, Zhengting, Zheng, Fengfeng, Huang, Xiaogang, Xie, Xuemei, Chen, Feihua, Ou, Hangbing, Lin, Guoxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805897/ https://www.ncbi.nlm.nih.gov/pubmed/34969357 http://dx.doi.org/10.1080/21655979.2021.2017628 |
Ejemplares similares
-
Unfolded protein response inhibits KAT2B/MLKL-mediated necroptosis of hepatocytes by promoting BMI1 level to ubiquitinate KAT2B
por: Huang, Xiaogang, et al.
Publicado: (2023) -
Role of miR-647 in human gastric cancer suppression
por: Cao, Wenlong, et al.
Publicado: (2017) -
Spotlight on the Expanding Role of miR-647 in Human Cancers
por: Jalili, Mohammadmahdi, et al.
Publicado: (2023) -
647. Diagnoses Associated with Temperature ≥104°F in Adults
por: Chi, Sharon, et al.
Publicado: (2019) -
Tumor promoter role of miR-647 in gastric cancer via repression of TP73
por: Zhang, Xiangqian, et al.
Publicado: (2018)